Dateline City: DURHAM, N.C. More Than 1,300 Patients Treated Worldwide with Tryton Stent System DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the company’s TRYTON Side Branch Stent™ System has been used in three cases in Israel for the first time. Yaron Almagor, M.D., director of the Interventional Cardiology and …

Dateline City: DURHAM, N.C. & Paris Tryton Stent Consistently Demonstrates Excellent Results Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced results from the company’s TRYTON Side Branch Stent™ System presented during a Trytonsponsored symposium in conjunction with the EuroPCR 2010 conference in Paris. Robert-Jan Van Geuns, M.D., senior cardiologist at Erasmus Medical …

Dateline City: RESEARCH TRIANGLE PARK, N.C. Studies Will Assess Tryton Side-Branch Stent in Real-World Settings More than 1,000 Patients Treated with Tryton System RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced completion of enrollment in E-Tryton 150 and E-Tryton Benelux, two European registry studies of the company’s TRYTON …

Dateline City: DURHAM, N.C. Company Celebrates 750th Implant DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in Portugal and Austria. Francisco Pereira Machado, M.D., of Hospital da Luz in Lisbon performed the first implant in Portugal. “The Tryton Side …